Global Smart Pills research

Smart Pills Comprehensive Study by Type (Capsule Endoscopy, Drug Delivery, Patient Monitoring), End User (Hospital, Diagnostic Center, Research Institute), Target (Area Esophagus, Small Intestine, Large Intestine Stomach), Disease Indication (Esophageal Diseases, Small Bowel Diseases, Colon Diseases Others) Players and Region - Global Market Outlook to 2026

Smart Pills Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Smart Pills Market?

Smart Pills is a medication that builds the psychological capacity of anybody taking it, regardless of whether the client is intellectually debilitated or typical. The Smart Pill goes through the GI plot and gathers weight, PH, and temperature information. After the case ingestion, an information beneficiary is worn on a belt or cord and records data gathered by the case. The information is downloaded to a PC furnishing doctors with the GI travel data to assess the stomach, little inside, and colon. The workplace visit will require around 30 minutes, at which point can go about typical day by day exercises. The visit doesn't need a medical clinic visit and doesn't open to radiation. SMART pill Conceptual PC work of art of two cerebrums inside a case, speaking to a savvy drug in an effectively regulated structure. Savvy drugs intend to invigorate districts of the mind, for example, the worldly and frontal projections, to improve insight, memory arrangement, and fixation. The name of the savvy pill presently alludes to any pill that can convey or control its conveyance of medication without the patient making a move past the underlying swallow.

The market study is being classified by Type (Capsule Endoscopy, Drug Delivery and Patient Monitoring) and major geographies with country level break-up.

CapsoVision, Inc. (United States), Given Imaging, Inc. (Israel), Medimetrics S.A. de C.V. (Mexico), Olympus Corporation (Japan), Bio-Images Research Limited (United Kingdom), Proteus (United States), Boston Scientific (United States), Fujifilm Holdings (Japan), Check-Cap (Israel) and Koninklijke Philips N.V.(Netherlands) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Medisafe (United States) and IntroMedic Co., Ltd (South Korea).

The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Smart Pills market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Smart Pills market by Type, Application and Region.

On the basis of geography, the market of Smart Pills has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increased Patient Preference for Minimally Invasive Surgeries
  • Growing usage of these non-invasive devices for the diagnosis of gastrointestinal disorders and cancer


Restraints
  • Need for Rapid Drug Development Process

Opportunities
  • The rising prevalence of chronic diseases such as breast cancer and colorectal cancer worldwide
  • The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies is booming the growth opportunities

Challenges
  • Lack of awareness regarding smart pills


Market Leaders and some development strategies

In Jan 2019 Proteus United States-based company has launched a new smart pill product named Chemotherapy Pills to Improve Outcomes in Cancer Patients. It is oral chemotherapy equipped with its ingestible sensor, which aims to help oncologists track treatment effectiveness and adherence in their cancer patients.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Smart Pills Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

Report Objectives / Segmentation Covered

By Type
  • Capsule Endoscopy
  • Drug Delivery
  • Patient Monitoring
By End User
  • Hospital
  • Diagnostic Center
  • Research Institute

By Target
  • Area Esophagus
  • Small Intestine
  • Large Intestine Stomach

By Disease Indication
  • Esophageal Diseases
  • Small Bowel Diseases
  • Colon Diseases Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Patient Preference for Minimally Invasive Surgeries\
      • 3.2.2. Growing usage of these non-invasive devices for the diagnosis of gastrointestinal disorders and cancer
    • 3.3. Market Challenges
      • 3.3.1. Lack of awareness regarding smart pills
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Smart Pills, by Type, End User , Target , Disease Indication and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Smart Pills (Value)
      • 5.2.1. Global Smart Pills by: Type (Value)
        • 5.2.1.1. Capsule Endoscopy
        • 5.2.1.2. Drug Delivery
        • 5.2.1.3. Patient Monitoring
      • 5.2.2. Global Smart Pills Region
        • 5.2.2.1. South America
          • 5.2.2.1.1. Brazil
          • 5.2.2.1.2. Argentina
          • 5.2.2.1.3. Rest of South America
        • 5.2.2.2. Asia Pacific
          • 5.2.2.2.1. China
          • 5.2.2.2.2. Japan
          • 5.2.2.2.3. India
          • 5.2.2.2.4. South Korea
          • 5.2.2.2.5. Taiwan
          • 5.2.2.2.6. Australia
          • 5.2.2.2.7. Rest of Asia-Pacific
        • 5.2.2.3. Europe
          • 5.2.2.3.1. Germany
          • 5.2.2.3.2. France
          • 5.2.2.3.3. Italy
          • 5.2.2.3.4. United Kingdom
          • 5.2.2.3.5. Netherlands
          • 5.2.2.3.6. Rest of Europe
        • 5.2.2.4. MEA
          • 5.2.2.4.1. Middle East
          • 5.2.2.4.2. Africa
        • 5.2.2.5. North America
          • 5.2.2.5.1. United States
          • 5.2.2.5.2. Canada
          • 5.2.2.5.3. Mexico
    • 5.3. Global Smart Pills (Volume)
      • 5.3.1. Global Smart Pills by: Type (Volume)
        • 5.3.1.1. Capsule Endoscopy
        • 5.3.1.2. Drug Delivery
        • 5.3.1.3. Patient Monitoring
      • 5.3.2. Global Smart Pills Region
        • 5.3.2.1. South America
          • 5.3.2.1.1. Brazil
          • 5.3.2.1.2. Argentina
          • 5.3.2.1.3. Rest of South America
        • 5.3.2.2. Asia Pacific
          • 5.3.2.2.1. China
          • 5.3.2.2.2. Japan
          • 5.3.2.2.3. India
          • 5.3.2.2.4. South Korea
          • 5.3.2.2.5. Taiwan
          • 5.3.2.2.6. Australia
          • 5.3.2.2.7. Rest of Asia-Pacific
        • 5.3.2.3. Europe
          • 5.3.2.3.1. Germany
          • 5.3.2.3.2. France
          • 5.3.2.3.3. Italy
          • 5.3.2.3.4. United Kingdom
          • 5.3.2.3.5. Netherlands
          • 5.3.2.3.6. Rest of Europe
        • 5.3.2.4. MEA
          • 5.3.2.4.1. Middle East
          • 5.3.2.4.2. Africa
        • 5.3.2.5. North America
          • 5.3.2.5.1. United States
          • 5.3.2.5.2. Canada
          • 5.3.2.5.3. Mexico
    • 5.4. Global Smart Pills (Price)
      • 5.4.1. Global Smart Pills by: Type (Price)
  • 6. Smart Pills: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. CapsoVision, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Given Imaging, Inc. (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medimetrics S.A. de C.V. (Mexico)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Olympus Corporation (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bio-Images Research Limited (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Proteus (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Boston Scientific (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Fujifilm Holdings (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Check-Cap (Israel)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Koninklijke Philips N.V.(Netherlands)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Smart Pills Sale, by Type, End User , Target , Disease Indication and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Smart Pills (Value)
      • 7.2.1. Global Smart Pills by: Type (Value)
        • 7.2.1.1. Capsule Endoscopy
        • 7.2.1.2. Drug Delivery
        • 7.2.1.3. Patient Monitoring
      • 7.2.2. Global Smart Pills Region
        • 7.2.2.1. South America
          • 7.2.2.1.1. Brazil
          • 7.2.2.1.2. Argentina
          • 7.2.2.1.3. Rest of South America
        • 7.2.2.2. Asia Pacific
          • 7.2.2.2.1. China
          • 7.2.2.2.2. Japan
          • 7.2.2.2.3. India
          • 7.2.2.2.4. South Korea
          • 7.2.2.2.5. Taiwan
          • 7.2.2.2.6. Australia
          • 7.2.2.2.7. Rest of Asia-Pacific
        • 7.2.2.3. Europe
          • 7.2.2.3.1. Germany
          • 7.2.2.3.2. France
          • 7.2.2.3.3. Italy
          • 7.2.2.3.4. United Kingdom
          • 7.2.2.3.5. Netherlands
          • 7.2.2.3.6. Rest of Europe
        • 7.2.2.4. MEA
          • 7.2.2.4.1. Middle East
          • 7.2.2.4.2. Africa
        • 7.2.2.5. North America
          • 7.2.2.5.1. United States
          • 7.2.2.5.2. Canada
          • 7.2.2.5.3. Mexico
    • 7.3. Global Smart Pills (Volume)
      • 7.3.1. Global Smart Pills by: Type (Volume)
        • 7.3.1.1. Capsule Endoscopy
        • 7.3.1.2. Drug Delivery
        • 7.3.1.3. Patient Monitoring
      • 7.3.2. Global Smart Pills Region
        • 7.3.2.1. South America
          • 7.3.2.1.1. Brazil
          • 7.3.2.1.2. Argentina
          • 7.3.2.1.3. Rest of South America
        • 7.3.2.2. Asia Pacific
          • 7.3.2.2.1. China
          • 7.3.2.2.2. Japan
          • 7.3.2.2.3. India
          • 7.3.2.2.4. South Korea
          • 7.3.2.2.5. Taiwan
          • 7.3.2.2.6. Australia
          • 7.3.2.2.7. Rest of Asia-Pacific
        • 7.3.2.3. Europe
          • 7.3.2.3.1. Germany
          • 7.3.2.3.2. France
          • 7.3.2.3.3. Italy
          • 7.3.2.3.4. United Kingdom
          • 7.3.2.3.5. Netherlands
          • 7.3.2.3.6. Rest of Europe
        • 7.3.2.4. MEA
          • 7.3.2.4.1. Middle East
          • 7.3.2.4.2. Africa
        • 7.3.2.5. North America
          • 7.3.2.5.1. United States
          • 7.3.2.5.2. Canada
          • 7.3.2.5.3. Mexico
    • 7.4. Global Smart Pills (Price)
      • 7.4.1. Global Smart Pills by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Smart Pills: by Type(USD Million)
  • Table 2. Smart Pills Capsule Endoscopy , by Region USD Million (2015-2020)
  • Table 3. Smart Pills Drug Delivery , by Region USD Million (2015-2020)
  • Table 4. Smart Pills Patient Monitoring , by Region USD Million (2015-2020)
  • Table 5. South America Smart Pills, by Country USD Million (2015-2020)
  • Table 6. South America Smart Pills, by Type USD Million (2015-2020)
  • Table 7. South America Smart Pills, by End User USD Million (2015-2020)
  • Table 8. South America Smart Pills, by Target USD Million (2015-2020)
  • Table 9. South America Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 10. Brazil Smart Pills, by Type USD Million (2015-2020)
  • Table 11. Brazil Smart Pills, by End User USD Million (2015-2020)
  • Table 12. Brazil Smart Pills, by Target USD Million (2015-2020)
  • Table 13. Brazil Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 14. Argentina Smart Pills, by Type USD Million (2015-2020)
  • Table 15. Argentina Smart Pills, by End User USD Million (2015-2020)
  • Table 16. Argentina Smart Pills, by Target USD Million (2015-2020)
  • Table 17. Argentina Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 18. Rest of South America Smart Pills, by Type USD Million (2015-2020)
  • Table 19. Rest of South America Smart Pills, by End User USD Million (2015-2020)
  • Table 20. Rest of South America Smart Pills, by Target USD Million (2015-2020)
  • Table 21. Rest of South America Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 22. Asia Pacific Smart Pills, by Country USD Million (2015-2020)
  • Table 23. Asia Pacific Smart Pills, by Type USD Million (2015-2020)
  • Table 24. Asia Pacific Smart Pills, by End User USD Million (2015-2020)
  • Table 25. Asia Pacific Smart Pills, by Target USD Million (2015-2020)
  • Table 26. Asia Pacific Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 27. China Smart Pills, by Type USD Million (2015-2020)
  • Table 28. China Smart Pills, by End User USD Million (2015-2020)
  • Table 29. China Smart Pills, by Target USD Million (2015-2020)
  • Table 30. China Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 31. Japan Smart Pills, by Type USD Million (2015-2020)
  • Table 32. Japan Smart Pills, by End User USD Million (2015-2020)
  • Table 33. Japan Smart Pills, by Target USD Million (2015-2020)
  • Table 34. Japan Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 35. India Smart Pills, by Type USD Million (2015-2020)
  • Table 36. India Smart Pills, by End User USD Million (2015-2020)
  • Table 37. India Smart Pills, by Target USD Million (2015-2020)
  • Table 38. India Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 39. South Korea Smart Pills, by Type USD Million (2015-2020)
  • Table 40. South Korea Smart Pills, by End User USD Million (2015-2020)
  • Table 41. South Korea Smart Pills, by Target USD Million (2015-2020)
  • Table 42. South Korea Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 43. Taiwan Smart Pills, by Type USD Million (2015-2020)
  • Table 44. Taiwan Smart Pills, by End User USD Million (2015-2020)
  • Table 45. Taiwan Smart Pills, by Target USD Million (2015-2020)
  • Table 46. Taiwan Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 47. Australia Smart Pills, by Type USD Million (2015-2020)
  • Table 48. Australia Smart Pills, by End User USD Million (2015-2020)
  • Table 49. Australia Smart Pills, by Target USD Million (2015-2020)
  • Table 50. Australia Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Smart Pills, by Type USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Smart Pills, by End User USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Smart Pills, by Target USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 55. Europe Smart Pills, by Country USD Million (2015-2020)
  • Table 56. Europe Smart Pills, by Type USD Million (2015-2020)
  • Table 57. Europe Smart Pills, by End User USD Million (2015-2020)
  • Table 58. Europe Smart Pills, by Target USD Million (2015-2020)
  • Table 59. Europe Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 60. Germany Smart Pills, by Type USD Million (2015-2020)
  • Table 61. Germany Smart Pills, by End User USD Million (2015-2020)
  • Table 62. Germany Smart Pills, by Target USD Million (2015-2020)
  • Table 63. Germany Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 64. France Smart Pills, by Type USD Million (2015-2020)
  • Table 65. France Smart Pills, by End User USD Million (2015-2020)
  • Table 66. France Smart Pills, by Target USD Million (2015-2020)
  • Table 67. France Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 68. Italy Smart Pills, by Type USD Million (2015-2020)
  • Table 69. Italy Smart Pills, by End User USD Million (2015-2020)
  • Table 70. Italy Smart Pills, by Target USD Million (2015-2020)
  • Table 71. Italy Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 72. United Kingdom Smart Pills, by Type USD Million (2015-2020)
  • Table 73. United Kingdom Smart Pills, by End User USD Million (2015-2020)
  • Table 74. United Kingdom Smart Pills, by Target USD Million (2015-2020)
  • Table 75. United Kingdom Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 76. Netherlands Smart Pills, by Type USD Million (2015-2020)
  • Table 77. Netherlands Smart Pills, by End User USD Million (2015-2020)
  • Table 78. Netherlands Smart Pills, by Target USD Million (2015-2020)
  • Table 79. Netherlands Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 80. Rest of Europe Smart Pills, by Type USD Million (2015-2020)
  • Table 81. Rest of Europe Smart Pills, by End User USD Million (2015-2020)
  • Table 82. Rest of Europe Smart Pills, by Target USD Million (2015-2020)
  • Table 83. Rest of Europe Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 84. MEA Smart Pills, by Country USD Million (2015-2020)
  • Table 85. MEA Smart Pills, by Type USD Million (2015-2020)
  • Table 86. MEA Smart Pills, by End User USD Million (2015-2020)
  • Table 87. MEA Smart Pills, by Target USD Million (2015-2020)
  • Table 88. MEA Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 89. Middle East Smart Pills, by Type USD Million (2015-2020)
  • Table 90. Middle East Smart Pills, by End User USD Million (2015-2020)
  • Table 91. Middle East Smart Pills, by Target USD Million (2015-2020)
  • Table 92. Middle East Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 93. Africa Smart Pills, by Type USD Million (2015-2020)
  • Table 94. Africa Smart Pills, by End User USD Million (2015-2020)
  • Table 95. Africa Smart Pills, by Target USD Million (2015-2020)
  • Table 96. Africa Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 97. North America Smart Pills, by Country USD Million (2015-2020)
  • Table 98. North America Smart Pills, by Type USD Million (2015-2020)
  • Table 99. North America Smart Pills, by End User USD Million (2015-2020)
  • Table 100. North America Smart Pills, by Target USD Million (2015-2020)
  • Table 101. North America Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 102. United States Smart Pills, by Type USD Million (2015-2020)
  • Table 103. United States Smart Pills, by End User USD Million (2015-2020)
  • Table 104. United States Smart Pills, by Target USD Million (2015-2020)
  • Table 105. United States Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 106. Canada Smart Pills, by Type USD Million (2015-2020)
  • Table 107. Canada Smart Pills, by End User USD Million (2015-2020)
  • Table 108. Canada Smart Pills, by Target USD Million (2015-2020)
  • Table 109. Canada Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 110. Mexico Smart Pills, by Type USD Million (2015-2020)
  • Table 111. Mexico Smart Pills, by End User USD Million (2015-2020)
  • Table 112. Mexico Smart Pills, by Target USD Million (2015-2020)
  • Table 113. Mexico Smart Pills, by Disease Indication USD Million (2015-2020)
  • Table 114. Smart Pills Sales: by Type(K Tons)
  • Table 115. Smart Pills Sales Capsule Endoscopy , by Region K Tons (2015-2020)
  • Table 116. Smart Pills Sales Drug Delivery , by Region K Tons (2015-2020)
  • Table 117. Smart Pills Sales Patient Monitoring , by Region K Tons (2015-2020)
  • Table 118. South America Smart Pills Sales, by Country K Tons (2015-2020)
  • Table 119. South America Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 120. South America Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 121. South America Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 122. South America Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 123. Brazil Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 124. Brazil Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 125. Brazil Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 126. Brazil Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 127. Argentina Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 128. Argentina Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 129. Argentina Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 130. Argentina Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 131. Rest of South America Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 132. Rest of South America Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 133. Rest of South America Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 134. Rest of South America Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 135. Asia Pacific Smart Pills Sales, by Country K Tons (2015-2020)
  • Table 136. Asia Pacific Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 137. Asia Pacific Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 138. Asia Pacific Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 139. Asia Pacific Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 140. China Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 141. China Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 142. China Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 143. China Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 144. Japan Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 145. Japan Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 146. Japan Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 147. Japan Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 148. India Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 149. India Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 150. India Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 151. India Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 152. South Korea Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 153. South Korea Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 154. South Korea Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 155. South Korea Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 156. Taiwan Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 157. Taiwan Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 158. Taiwan Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 159. Taiwan Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 160. Australia Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 161. Australia Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 162. Australia Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 163. Australia Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 164. Rest of Asia-Pacific Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 165. Rest of Asia-Pacific Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 166. Rest of Asia-Pacific Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 167. Rest of Asia-Pacific Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 168. Europe Smart Pills Sales, by Country K Tons (2015-2020)
  • Table 169. Europe Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 170. Europe Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 171. Europe Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 172. Europe Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 173. Germany Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 174. Germany Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 175. Germany Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 176. Germany Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 177. France Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 178. France Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 179. France Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 180. France Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 181. Italy Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 182. Italy Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 183. Italy Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 184. Italy Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 185. United Kingdom Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 186. United Kingdom Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 187. United Kingdom Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 188. United Kingdom Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 189. Netherlands Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 190. Netherlands Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 191. Netherlands Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 192. Netherlands Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 193. Rest of Europe Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 194. Rest of Europe Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 195. Rest of Europe Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 196. Rest of Europe Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 197. MEA Smart Pills Sales, by Country K Tons (2015-2020)
  • Table 198. MEA Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 199. MEA Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 200. MEA Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 201. MEA Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 202. Middle East Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 203. Middle East Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 204. Middle East Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 205. Middle East Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 206. Africa Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 207. Africa Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 208. Africa Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 209. Africa Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 210. North America Smart Pills Sales, by Country K Tons (2015-2020)
  • Table 211. North America Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 212. North America Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 213. North America Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 214. North America Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 215. United States Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 216. United States Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 217. United States Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 218. United States Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 219. Canada Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 220. Canada Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 221. Canada Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 222. Canada Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 223. Mexico Smart Pills Sales, by Type K Tons (2015-2020)
  • Table 224. Mexico Smart Pills Sales, by End User K Tons (2015-2020)
  • Table 225. Mexico Smart Pills Sales, by Target K Tons (2015-2020)
  • Table 226. Mexico Smart Pills Sales, by Disease Indication K Tons (2015-2020)
  • Table 227. Smart Pills: by Type(USD/Units)
  • Table 228. Company Basic Information, Sales Area and Its Competitors
  • Table 229. Company Basic Information, Sales Area and Its Competitors
  • Table 230. Company Basic Information, Sales Area and Its Competitors
  • Table 231. Company Basic Information, Sales Area and Its Competitors
  • Table 232. Company Basic Information, Sales Area and Its Competitors
  • Table 233. Company Basic Information, Sales Area and Its Competitors
  • Table 234. Company Basic Information, Sales Area and Its Competitors
  • Table 235. Company Basic Information, Sales Area and Its Competitors
  • Table 236. Company Basic Information, Sales Area and Its Competitors
  • Table 237. Company Basic Information, Sales Area and Its Competitors
  • Table 238. Smart Pills: by Type(USD Million)
  • Table 239. Smart Pills Capsule Endoscopy , by Region USD Million (2021-2026)
  • Table 240. Smart Pills Drug Delivery , by Region USD Million (2021-2026)
  • Table 241. Smart Pills Patient Monitoring , by Region USD Million (2021-2026)
  • Table 242. South America Smart Pills, by Country USD Million (2021-2026)
  • Table 243. South America Smart Pills, by Type USD Million (2021-2026)
  • Table 244. South America Smart Pills, by End User USD Million (2021-2026)
  • Table 245. South America Smart Pills, by Target USD Million (2021-2026)
  • Table 246. South America Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 247. Brazil Smart Pills, by Type USD Million (2021-2026)
  • Table 248. Brazil Smart Pills, by End User USD Million (2021-2026)
  • Table 249. Brazil Smart Pills, by Target USD Million (2021-2026)
  • Table 250. Brazil Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 251. Argentina Smart Pills, by Type USD Million (2021-2026)
  • Table 252. Argentina Smart Pills, by End User USD Million (2021-2026)
  • Table 253. Argentina Smart Pills, by Target USD Million (2021-2026)
  • Table 254. Argentina Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 255. Rest of South America Smart Pills, by Type USD Million (2021-2026)
  • Table 256. Rest of South America Smart Pills, by End User USD Million (2021-2026)
  • Table 257. Rest of South America Smart Pills, by Target USD Million (2021-2026)
  • Table 258. Rest of South America Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 259. Asia Pacific Smart Pills, by Country USD Million (2021-2026)
  • Table 260. Asia Pacific Smart Pills, by Type USD Million (2021-2026)
  • Table 261. Asia Pacific Smart Pills, by End User USD Million (2021-2026)
  • Table 262. Asia Pacific Smart Pills, by Target USD Million (2021-2026)
  • Table 263. Asia Pacific Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 264. China Smart Pills, by Type USD Million (2021-2026)
  • Table 265. China Smart Pills, by End User USD Million (2021-2026)
  • Table 266. China Smart Pills, by Target USD Million (2021-2026)
  • Table 267. China Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 268. Japan Smart Pills, by Type USD Million (2021-2026)
  • Table 269. Japan Smart Pills, by End User USD Million (2021-2026)
  • Table 270. Japan Smart Pills, by Target USD Million (2021-2026)
  • Table 271. Japan Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 272. India Smart Pills, by Type USD Million (2021-2026)
  • Table 273. India Smart Pills, by End User USD Million (2021-2026)
  • Table 274. India Smart Pills, by Target USD Million (2021-2026)
  • Table 275. India Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 276. South Korea Smart Pills, by Type USD Million (2021-2026)
  • Table 277. South Korea Smart Pills, by End User USD Million (2021-2026)
  • Table 278. South Korea Smart Pills, by Target USD Million (2021-2026)
  • Table 279. South Korea Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 280. Taiwan Smart Pills, by Type USD Million (2021-2026)
  • Table 281. Taiwan Smart Pills, by End User USD Million (2021-2026)
  • Table 282. Taiwan Smart Pills, by Target USD Million (2021-2026)
  • Table 283. Taiwan Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 284. Australia Smart Pills, by Type USD Million (2021-2026)
  • Table 285. Australia Smart Pills, by End User USD Million (2021-2026)
  • Table 286. Australia Smart Pills, by Target USD Million (2021-2026)
  • Table 287. Australia Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 288. Rest of Asia-Pacific Smart Pills, by Type USD Million (2021-2026)
  • Table 289. Rest of Asia-Pacific Smart Pills, by End User USD Million (2021-2026)
  • Table 290. Rest of Asia-Pacific Smart Pills, by Target USD Million (2021-2026)
  • Table 291. Rest of Asia-Pacific Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 292. Europe Smart Pills, by Country USD Million (2021-2026)
  • Table 293. Europe Smart Pills, by Type USD Million (2021-2026)
  • Table 294. Europe Smart Pills, by End User USD Million (2021-2026)
  • Table 295. Europe Smart Pills, by Target USD Million (2021-2026)
  • Table 296. Europe Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 297. Germany Smart Pills, by Type USD Million (2021-2026)
  • Table 298. Germany Smart Pills, by End User USD Million (2021-2026)
  • Table 299. Germany Smart Pills, by Target USD Million (2021-2026)
  • Table 300. Germany Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 301. France Smart Pills, by Type USD Million (2021-2026)
  • Table 302. France Smart Pills, by End User USD Million (2021-2026)
  • Table 303. France Smart Pills, by Target USD Million (2021-2026)
  • Table 304. France Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 305. Italy Smart Pills, by Type USD Million (2021-2026)
  • Table 306. Italy Smart Pills, by End User USD Million (2021-2026)
  • Table 307. Italy Smart Pills, by Target USD Million (2021-2026)
  • Table 308. Italy Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 309. United Kingdom Smart Pills, by Type USD Million (2021-2026)
  • Table 310. United Kingdom Smart Pills, by End User USD Million (2021-2026)
  • Table 311. United Kingdom Smart Pills, by Target USD Million (2021-2026)
  • Table 312. United Kingdom Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 313. Netherlands Smart Pills, by Type USD Million (2021-2026)
  • Table 314. Netherlands Smart Pills, by End User USD Million (2021-2026)
  • Table 315. Netherlands Smart Pills, by Target USD Million (2021-2026)
  • Table 316. Netherlands Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 317. Rest of Europe Smart Pills, by Type USD Million (2021-2026)
  • Table 318. Rest of Europe Smart Pills, by End User USD Million (2021-2026)
  • Table 319. Rest of Europe Smart Pills, by Target USD Million (2021-2026)
  • Table 320. Rest of Europe Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 321. MEA Smart Pills, by Country USD Million (2021-2026)
  • Table 322. MEA Smart Pills, by Type USD Million (2021-2026)
  • Table 323. MEA Smart Pills, by End User USD Million (2021-2026)
  • Table 324. MEA Smart Pills, by Target USD Million (2021-2026)
  • Table 325. MEA Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 326. Middle East Smart Pills, by Type USD Million (2021-2026)
  • Table 327. Middle East Smart Pills, by End User USD Million (2021-2026)
  • Table 328. Middle East Smart Pills, by Target USD Million (2021-2026)
  • Table 329. Middle East Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 330. Africa Smart Pills, by Type USD Million (2021-2026)
  • Table 331. Africa Smart Pills, by End User USD Million (2021-2026)
  • Table 332. Africa Smart Pills, by Target USD Million (2021-2026)
  • Table 333. Africa Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 334. North America Smart Pills, by Country USD Million (2021-2026)
  • Table 335. North America Smart Pills, by Type USD Million (2021-2026)
  • Table 336. North America Smart Pills, by End User USD Million (2021-2026)
  • Table 337. North America Smart Pills, by Target USD Million (2021-2026)
  • Table 338. North America Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 339. United States Smart Pills, by Type USD Million (2021-2026)
  • Table 340. United States Smart Pills, by End User USD Million (2021-2026)
  • Table 341. United States Smart Pills, by Target USD Million (2021-2026)
  • Table 342. United States Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 343. Canada Smart Pills, by Type USD Million (2021-2026)
  • Table 344. Canada Smart Pills, by End User USD Million (2021-2026)
  • Table 345. Canada Smart Pills, by Target USD Million (2021-2026)
  • Table 346. Canada Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 347. Mexico Smart Pills, by Type USD Million (2021-2026)
  • Table 348. Mexico Smart Pills, by End User USD Million (2021-2026)
  • Table 349. Mexico Smart Pills, by Target USD Million (2021-2026)
  • Table 350. Mexico Smart Pills, by Disease Indication USD Million (2021-2026)
  • Table 351. Smart Pills Sales: by Type(K Tons)
  • Table 352. Smart Pills Sales Capsule Endoscopy , by Region K Tons (2021-2026)
  • Table 353. Smart Pills Sales Drug Delivery , by Region K Tons (2021-2026)
  • Table 354. Smart Pills Sales Patient Monitoring , by Region K Tons (2021-2026)
  • Table 355. South America Smart Pills Sales, by Country K Tons (2021-2026)
  • Table 356. South America Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 357. South America Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 358. South America Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 359. South America Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 360. Brazil Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 361. Brazil Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 362. Brazil Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 363. Brazil Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 364. Argentina Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 365. Argentina Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 366. Argentina Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 367. Argentina Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 368. Rest of South America Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 369. Rest of South America Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 370. Rest of South America Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 371. Rest of South America Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 372. Asia Pacific Smart Pills Sales, by Country K Tons (2021-2026)
  • Table 373. Asia Pacific Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 374. Asia Pacific Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 375. Asia Pacific Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 376. Asia Pacific Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 377. China Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 378. China Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 379. China Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 380. China Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 381. Japan Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 382. Japan Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 383. Japan Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 384. Japan Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 385. India Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 386. India Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 387. India Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 388. India Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 389. South Korea Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 390. South Korea Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 391. South Korea Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 392. South Korea Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 393. Taiwan Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 394. Taiwan Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 395. Taiwan Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 396. Taiwan Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 397. Australia Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 398. Australia Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 399. Australia Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 400. Australia Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 401. Rest of Asia-Pacific Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 402. Rest of Asia-Pacific Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 403. Rest of Asia-Pacific Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 404. Rest of Asia-Pacific Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 405. Europe Smart Pills Sales, by Country K Tons (2021-2026)
  • Table 406. Europe Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 407. Europe Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 408. Europe Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 409. Europe Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 410. Germany Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 411. Germany Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 412. Germany Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 413. Germany Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 414. France Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 415. France Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 416. France Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 417. France Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 418. Italy Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 419. Italy Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 420. Italy Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 421. Italy Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 422. United Kingdom Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 423. United Kingdom Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 424. United Kingdom Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 425. United Kingdom Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 426. Netherlands Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 427. Netherlands Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 428. Netherlands Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 429. Netherlands Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 430. Rest of Europe Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 431. Rest of Europe Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 432. Rest of Europe Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 433. Rest of Europe Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 434. MEA Smart Pills Sales, by Country K Tons (2021-2026)
  • Table 435. MEA Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 436. MEA Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 437. MEA Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 438. MEA Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 439. Middle East Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 440. Middle East Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 441. Middle East Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 442. Middle East Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 443. Africa Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 444. Africa Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 445. Africa Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 446. Africa Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 447. North America Smart Pills Sales, by Country K Tons (2021-2026)
  • Table 448. North America Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 449. North America Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 450. North America Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 451. North America Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 452. United States Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 453. United States Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 454. United States Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 455. United States Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 456. Canada Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 457. Canada Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 458. Canada Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 459. Canada Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 460. Mexico Smart Pills Sales, by Type K Tons (2021-2026)
  • Table 461. Mexico Smart Pills Sales, by End User K Tons (2021-2026)
  • Table 462. Mexico Smart Pills Sales, by Target K Tons (2021-2026)
  • Table 463. Mexico Smart Pills Sales, by Disease Indication K Tons (2021-2026)
  • Table 464. Smart Pills: by Type(USD/Units)
  • Table 465. Research Programs/Design for This Report
  • Table 466. Key Data Information from Secondary Sources
  • Table 467. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Smart Pills: by Type USD Million (2015-2020)
  • Figure 5. South America Smart Pills Share (%), by Country
  • Figure 6. Asia Pacific Smart Pills Share (%), by Country
  • Figure 7. Europe Smart Pills Share (%), by Country
  • Figure 8. MEA Smart Pills Share (%), by Country
  • Figure 9. North America Smart Pills Share (%), by Country
  • Figure 10. Global Smart Pills: by Type K Tons (2015-2020)
  • Figure 11. South America Smart Pills Share (%), by Country
  • Figure 12. Asia Pacific Smart Pills Share (%), by Country
  • Figure 13. Europe Smart Pills Share (%), by Country
  • Figure 14. MEA Smart Pills Share (%), by Country
  • Figure 15. North America Smart Pills Share (%), by Country
  • Figure 16. Global Smart Pills: by Type USD/Units (2015-2020)
  • Figure 17. Global Smart Pills share by Players 2020 (%)
  • Figure 18. Global Smart Pills share by Players (Top 3) 2020(%)
  • Figure 19. Global Smart Pills share by Players (Top 5) 2020(%)
  • Figure 20. BCG Matrix for key Companies
  • Figure 21. CapsoVision, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. CapsoVision, Inc. (United States) Revenue: by Geography 2020
  • Figure 23. Given Imaging, Inc. (Israel) Revenue, Net Income and Gross profit
  • Figure 24. Given Imaging, Inc. (Israel) Revenue: by Geography 2020
  • Figure 25. Medimetrics S.A. de C.V. (Mexico) Revenue, Net Income and Gross profit
  • Figure 26. Medimetrics S.A. de C.V. (Mexico) Revenue: by Geography 2020
  • Figure 27. Olympus Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 28. Olympus Corporation (Japan) Revenue: by Geography 2020
  • Figure 29. Bio-Images Research Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Bio-Images Research Limited (United Kingdom) Revenue: by Geography 2020
  • Figure 31. Proteus (United States) Revenue, Net Income and Gross profit
  • Figure 32. Proteus (United States) Revenue: by Geography 2020
  • Figure 33. Boston Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 34. Boston Scientific (United States) Revenue: by Geography 2020
  • Figure 35. Fujifilm Holdings (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Fujifilm Holdings (Japan) Revenue: by Geography 2020
  • Figure 37. Check-Cap (Israel) Revenue, Net Income and Gross profit
  • Figure 38. Check-Cap (Israel) Revenue: by Geography 2020
  • Figure 39. Koninklijke Philips N.V.(Netherlands) Revenue, Net Income and Gross profit
  • Figure 40. Koninklijke Philips N.V.(Netherlands) Revenue: by Geography 2020
  • Figure 41. Global Smart Pills: by Type USD Million (2021-2026)
  • Figure 42. South America Smart Pills Share (%), by Country
  • Figure 43. Asia Pacific Smart Pills Share (%), by Country
  • Figure 44. Europe Smart Pills Share (%), by Country
  • Figure 45. MEA Smart Pills Share (%), by Country
  • Figure 46. North America Smart Pills Share (%), by Country
  • Figure 47. Global Smart Pills: by Type K Tons (2021-2026)
  • Figure 48. South America Smart Pills Share (%), by Country
  • Figure 49. Asia Pacific Smart Pills Share (%), by Country
  • Figure 50. Europe Smart Pills Share (%), by Country
  • Figure 51. MEA Smart Pills Share (%), by Country
  • Figure 52. North America Smart Pills Share (%), by Country
  • Figure 53. Global Smart Pills: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • CapsoVision, Inc. (United States)
  • Given Imaging, Inc. (Israel)
  • Medimetrics S.A. de C.V. (Mexico)
  • Olympus Corporation (Japan)
  • Bio-Images Research Limited (United Kingdom)
  • Proteus (United States)
  • Boston Scientific (United States)
  • Fujifilm Holdings (Japan)
  • Check-Cap (Israel)
  • Koninklijke Philips N.V.(Netherlands)
Additional players considered in the study are as follows:
Medisafe (United States) , IntroMedic Co., Ltd (South Korea)
Select User Access Type

Key Highlights of Report


Oct 2021 237 Pages 92 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Smart Pills research Quantitative research analysis
Global Smart Pills research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increased Patient Preference for Minimally Invasive Surgeries " is seen as one of major growth factors of Smart Pills Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
United States will lead Smart Pills Market in coming years.

Know More About Global Smart Pills research Report?

Have a Query? Click Here

Other Related Reports

Artificial Tears Comprehensive Study by Type (Artificial Tear Liquid, Artificial Tear Ointment), Application (Dry Eyes Treatment, Contact Lenses Moisten, Others), End User (Hospital, Clinic, Other) P...
$ 3500
Archwire Comprehensive Study by Type (Nickel Titanium Archwire, Thermal Nickel Titanium Archwire, Copper Nickel Titanium Archwire, Beta Titanium Archwire, Stainless Steel Archwire, Coated Nickel Tita...
$ 3750
Baby Nipples Comprehensive Study by Type (Thumb-type Baby Nipples, Spiral Baby Nipples), Application (Newborn, 3-6 Months Old, >6 Months Old), Sales Channel (Online Sales, Offline Sales) Players and ...
$ 3500
Cannabis Oil Comprehensive Study by Type (Organic, Non-Organic), Application (Recreational, Medical), Components (Cannabidiol (CBD), Delta-9 Tetrahydrocannabinol (THC)) Players and Region - Global Ma...
$ 3500
Clinical Nutrition Comprehensive Study by Type (Oral Nutrition, Enteral Nutrition, Parenteral Nutrition), Application (Infant and Child, Adults, Geriatrics), Category (Micronutrients, Macronutrients)...
$ 3800
Powder Free Gloves Comprehensive Study by Type (Disposable, Reusable), Application (Sterile Laboratory, Treatment Room, Hospitals, Food Service, Othe), Distribution Channel (Pharmacies, Drug Stores, ...
$ 3650